Skip Navigation
United States Flag

An official website of the United States government. Here's how you know >

Change Font Size

Foster Care: Statesí Protocols for the Use and Monitoring of Psychotropic Medications for Children in Foster Care

Psychotropic medications are used to treat mental health disorders such as schizophrenia, depression, bipolar disorder, anxiety disorders, and attention deficit/hyperactivity disorder. Pursuant to section 422(b)(15)(A) of the SSA, each State must develop a plan for ongoing oversight and coordination of health services for children in foster care, including oversight of prescription medicines, e.g., appropriate use and monitoring of psychotropic medications.† We will describe Statesí protocols for the appropriate use and monitoring of psychotropic medications for children in foster care. †For selected States, we will determine whether a sample of children in foster care enrolled in Medicaid received psychotropic medications in accordance with their State's protocols.† Because ACF is responsible for the oversight of Statesí foster care programs, we will determine the extent to which the Agency ensures that children in foster care receive psychotropic drugs in accordance with Statesí protocols.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
Nov-16 Administration for Children and Families Foster Care: Statesí Protocols for the Use and Monitoring of Psychotropic Medications for Children in Foster Care Office of Evaluation and Inspections OEI-07-15-00380 2018

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201